Development of fluorine-18 labelled peptidic PET tracers for imaging active tissue transglutaminase

This study aims at developing a TG2 PET tracer based on the peptidic irreversible TG2 inhibitor Z006.

Source: Nuclear Medicine and Biology - October 17, 2016 Category: Nuclear Medicine Authors: Berend van der Wildt, Micha M.M. Wilhelmus, Esther J.M. Kooijman, Cornelis A.M. Jongenelen, Robert C. Schuit, Christian B üchold, Ralf Pasternack, Adriaan A. Lammertsma, Benjamin Drukarch, Albert D. Windhorst Source Type: research